Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,071 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oncologic and Safety Outcomes for Retrograde and Antegrade Endoscopic Surgeries for Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-analysis.
Laukhtina E, Kawada T, Quhal F, Yanagisawa T, Rajwa P, von Deimling M, Pallauf M, Bianchi A, Majdoub M, Enikeev D, Fajkovic H, Teoh JY, Rouprêt M, Gontero P, Shariat SF. Laukhtina E, et al. Among authors: roupret m. Eur Urol Focus. 2023 Mar;9(2):258-263. doi: 10.1016/j.euf.2022.11.014. Epub 2022 Nov 22. Eur Urol Focus. 2023. PMID: 36428210 Free article. Review.
Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study.
van Rhijn BWG, Hentschel AE, Bründl J, Compérat EM, Hernández V, Čapoun O, Bruins HM, Cohen D, Rouprêt M, Shariat SF, Mostafid AH, Zigeuner R, Dominguez-Escrig JL, Burger M, Soukup V, Gontero P, Palou J, van der Kwast TH, Babjuk M, Sylvester RJ; Multi-center EAU Non-Muscle-Invasive Bladder Cancer Guidelines Panel Study Consortium on the WHO1973 WHO 2004 2016 Classification Systems for Grade. van Rhijn BWG, et al. Among authors: roupret m. Eur Urol Oncol. 2021 Apr;4(2):182-191. doi: 10.1016/j.euo.2020.12.002. Epub 2021 Jan 8. Eur Urol Oncol. 2021. PMID: 33423944
Biological and prognostic implications of biopsy upgrading for high-grade upper tract urothelial carcinoma at nephroureterectomy.
Katayama S, Pradere B, Grossman NC, Potretzke AM, Boorjian SA, Ghoreifi A, Daneshmand S, Djaladat H, Sfakianos JP, Mari A, Khene ZE, D'Andrea D, Hayakawa N, Breda A, Fontana M, Fujita K, Antonelli A, van Doeveren T, Steinbach C, Mori K, Laukhtina E, Rouprêt M, Margulis V, Karakiewicz PI, Araki M, Compérat E, Nasu Y, Shariat SF. Katayama S, et al. Among authors: roupret m. Int J Urol. 2023 Jan;30(1):63-69. doi: 10.1111/iju.15061. Epub 2022 Nov 9. Int J Urol. 2023. PMID: 36349904 Free PMC article.
Oncologic and Safety Outcomes for Endoscopic Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An Updated Systematic Review and Meta-analysis.
Kawada T, Laukhtina E, Quhal F, Yanagisawa T, Rajwa P, Pallauf M, von Deimling M, Bianchi A, Pradere B, Fajkovic H, Enikeev D, Gontero P, Rouprêt M, Seisen T, Araki M, Shariat SF. Kawada T, et al. Among authors: roupret m. Eur Urol Focus. 2023 Mar;9(2):236-240. doi: 10.1016/j.euf.2022.11.016. Epub 2022 Nov 30. Eur Urol Focus. 2023. PMID: 36463089 Free article. Review.
Salvage Radical Prostatectomy for Recurrent Prostate Cancer Following First-line Nonsurgical Treatment: Validation of the European Association of Urology Criteria in a Large, Multicenter, Contemporary Cohort.
Calleris G, Marra G, Benfant N, Rajwa P, Ahmed M, Abreu A, Cacciamani G, Ghoreifi A, Ribeiro L, Westhofen T, Tourinho-Barbosa R, Raskin Y, Veerman H, Albisinni S, Smith JA, Rouprêt M, Oderda M, Massari E, Persad R, Van Der Poel H, Joniau S, Sanchez-Salas R, Kretschmer A, Cathcart P, Gill I, Karnes RJ, Tilki D, Shariat SF, Touijer K, Gontero P. Calleris G, et al. Among authors: roupret m. Eur Urol Focus. 2023 Jul;9(4):645-649. doi: 10.1016/j.euf.2023.01.006. Epub 2023 Jan 20. Eur Urol Focus. 2023. PMID: 36682962
A systematic review and meta-analysis to evaluate the diagnostic accuracy of PSMA PET/CT in the initial staging of prostate cancer.
Mari A, Cadenar A, Giudici S, Cianchi G, Albisinni S, Autorino R, Di Maida F, Gandaglia G, Mir MC, Valerio M, Marra G, Zattoni F, Bianchi L, Lombardo R, Shariat SF, Roupret M, Bauckneht M, Vaggelli L, De Nunzio C, Minervini A. Mari A, et al. Among authors: roupret m. Prostate Cancer Prostatic Dis. 2024 May 31. doi: 10.1038/s41391-024-00850-y. Online ahead of print. Prostate Cancer Prostatic Dis. 2024. PMID: 38822051 Review.
Clinical Significance of Tumor Location for Ureteroscopic Tumor Grading in Upper Tract Urothelial Carcinoma.
Katayama S, Pradere B, Grossman NC, Potretzke AM, Boorjian SA, Ghoreifi A, Daneshmand S, Djaladat H, Sfakianos JP, Mari A, Khene ZE, D'andrea D, Hayakawa N, Fujita K, Heindenreich A, Raman JD, Roumiguié M, Abdollah F, Breda A, Fontana M, Rouprêt M, Margulis V, Karakiewicz PI, Araki M, Nasu Y, Shariat SF. Katayama S, et al. Among authors: roupret m. J Endourol. 2024 Nov;38(11):1156-1163. doi: 10.1089/end.2024.0335. Epub 2024 Sep 25. J Endourol. 2024. PMID: 39264866
Tissue-based Biomarkers Steering Clinical Decisions in Patients with Urothelial Cancer.
Afferi L, Cimadamore A, Gallioli A, Pradere B, Mertens LS, Marcq G, Anguera G, Necchi A, Briganti A, Montorsi F, Rouprêt M, Gontero P, Breda A, Moschini M; European Association of Urology Young Academic Urologists Urothelial Carcinoma Working Group. Afferi L, et al. Among authors: roupret m. Eur Urol. 2025 Jan;87(1):1-4. doi: 10.1016/j.eururo.2024.08.033. Epub 2024 Sep 11. Eur Urol. 2025. PMID: 39266382
The role of intravesical chemotherapy following nephroureterectomy in upper tract urothelial carcinoma: A systematic review and meta-analysis.
Moretto S, Piccolini A, Gallioli A, Contieri R, Buffi N, Lughezzani G, Breda A, Baboudjian M, van Rhijn BW, Roupret M, Uleri A, Pradere B. Moretto S, et al. Among authors: roupret m. Urol Oncol. 2024 Nov 25:S1078-1439(24)00715-4. doi: 10.1016/j.urolonc.2024.10.035. Online ahead of print. Urol Oncol. 2024. PMID: 39592361 Review.
1,071 results